CD55 deficiency
| CD55 deficiency | |
|---|---|
| Other names | CHAPLE Syndrome, DAF deficiency |
| CHAPLE Syndrome has an autosomal recessive pattern of inheritance | |
| Specialty | Medical genetics |
| Symptoms | Gastrointestinal symptoms, edema, malnutrition, hypoalbuminemia, hypogammaglobulinemia, intestinal lymphangiectasia |
| Causes | Genetic (autosomal recessive) |
| Diagnostic method | Genetic testing |
| Treatment | Eculizumab |
CD55 deficiency, also called DAF deficiency or CHAPLE syndrome, is a rare genetic disorder of the immune system. CHAPLE stands for "CD55 deficiency with hyper-activation of complement, angiopathic thrombosis, and severe protein-losing enteropathy (PLE)."[1] The disorder usually manifests in childhood and can be life-threatening. This condition was described by Özen, et al. in 2017.[1]
- ^ a b Ozen A, Comrie WA, Ardy RC, Domínguez Conde C, Dalgic B, Beser ÖF, et al. (July 2017). "CD55 Deficiency, Early-Onset Protein-Losing Enteropathy, and Thrombosis". The New England Journal of Medicine. 377 (1): 52–61. doi:10.1056/NEJMoa1615887. PMC 6690356. PMID 28657829.